• kinsnik@lemmy.world
    link
    fedilink
    arrow-up
    27
    ·
    8 个月前

    i wish that they would also reschedule lsd and psilocybin to schedule III, but at least some progress is better than no progress

      • jeansburger@lemmy.world
        link
        fedilink
        arrow-up
        4
        ·
        8 个月前

        It is arbitrary. While what classification a substance is may have some grounding in research, it’s mostly up to what interest group has either lobbied to get something under or whatever group law enforcement wants to be able to get easy charges for. Cannabis was Sched I because it made it easy for law enforcement to get big sentences for minorities and the counter culture participants of the day. Same thing with LSD and psilocybin.

        All the DEA scheduling is just pick and choose your charge for whatever ideological ax they want to grind. Hence why things don’t line up with reality

    • antlion@lemmy.dbzer0.com
      link
      fedilink
      arrow-up
      8
      ·
      8 个月前

      And MDMA? It shows a lot of promise in therapeutic use. Schedule 1 is for substances with “no currently accepted medical treatment use”.

      • kinsnik@lemmy.world
        link
        fedilink
        arrow-up
        2
        ·
        8 个月前

        Yeah, MDMA also doesn’t belong in schedule I, although it is definitely more risky than lsd and mushrooms

          • kinsnik@lemmy.world
            link
            fedilink
            arrow-up
            2
            ·
            8 个月前

            Overdose of MDMA can cause seratonin syndrome, which can be fatal; and long term use might be linked to depression and anxiety (again, by the way it interacts with seratonin)

            It definitely should be rescheduled too, since it is not dangerous enough and definitely has potential for medical use (couple therapy was it’s original use)